Tag: RAS Inhibitors
Flexibility for clinicians in managing RAS inhibitors in noncardiac surgery
Editor's Note A new study, the Stop-or-Not Trial, has found no significant difference in outcomes for patients undergoing noncardiac surgery who either continued or discontinued their renin-angiotensin system (RAS) inhibitor therapy, MedPage Today August 31 reports. The randomized clinical trial, which included over 2,200 patients, reported the rate of death…
Free Daily News
- Vertical integration reshaping US healthcare: Impact on cost, access
- ChristianaCare, Atlas Healthcare form joint venture to expand ASC network
- CMS calls for demonstrations of AI technology in healthcare
- Study: Adjuvant nivolumab reduces risk of death, lung cancer recurrence
- Analysis: Hospital safety, quality measures surpass pre-pandemic levels
- FDA: Class 1 infusion system recall expanded
- Anesthesia staffing, communication, patient safety: Q&A with OR Manager Conference speakers
- FDA designates Class 1 recall for infusion system components
- WHO, Joint Commission mark World Patient Safety Day
- Study: COVID-19 boosts risk of postoperative complications, longer hospital stays for emergency surgery patients
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement